Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Venous Thromboembolism 18Neoplasms 11Venous Thrombosis 9Pulmonary Embolism 9Thrombosis 5Multiple Myeloma 4Pancreatic Neoplasms 2Neoplasm Metastasis 2Lymphoma 2Intracranial Thrombosis 2Hematologic Neoplasms 2Carcinoma, Hepatocellular 2Urinary Bladder Neoplasms 1Upper Extremity Deep Vein Thrombosis 1Thromboprophylaxis 1Thromboembolism 1Thrombocytopenia 1Thrombocythemia, Essential 1Stomach Neoplasms 1Primary Myelofibrosis 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Polycythemia Vera 1Neoplasms, Plasma Cell 1Myeloproliferative Disorders 1Mesenteric Ischemia 1Leukemia 1Head and Neck Neoplasms 1Glioma 1Glioblastoma 1Gastrointestinal Stromal Tumors 1

Interventions

Cyclophosphamide 409Methotrexate 246Cytarabine 231Vincristine 188fludarabine phosphate 172Dexamethasone 169fludarabine 143Etoposide 143Peripheral Blood Stem Cell Transplantation 136Filgrastim 132Whole-Body Irradiation 116Mycophenolic Acid 115Busulfan 112Doxorubicin 109Tacrolimus 106Mercaptopurine 105Cyclosporine 95Radiotherapy 93Melphalan 93Rituximab 90pegaspargase 88Prednisone 84Asparaginase 84Daunorubicin 82Granulocyte Colony-Stimulating Factor 74blinatumomab 72Antilymphocyte Serum 71Calcium Dobesilate 69Clofarabine 58Thiotepa 55

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Precursor Cell Lymphoblastic Leukemia-Lymphoma × apixaban × Clear all
NCT02369653 2022-03-08

A Study of the Safety and Effectiveness of Apixaban in Preventing Blood Clots in Children With Leukemia Who Have a Central Venous Catheter and Are Treated With Asparaginase

Bristol-Myers Squibb

Phase 3 Completed
512 enrolled 26 charts
LymphoidOther hematologic neoplasm

Lymphoma, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡